Evidence map›Paper›PMID 34866532›Full record

ArticleBioengineered2021

Gastrodin attenuates perfluorooctanoic acid-induced liver injury by regulating gut microbiota composition in mice.

Shumin Ma, Yanyan Sun, Xueting Zheng, Yang Yang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Gastrodin: a comprehensive pharmacological review.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  6. Article
  7. Article
  8. Review on pharmacological effects of gastrodin.Archives of pharmacal research · 2023
    Review
  9. Journal of advanced veterinary and animal research · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shumin MaDepartment of Hepatology, Shandong Provincial Public Health Clinical Center, Jinan, China.
Yanyan SunFever Observation Ward, Shandong Provincial Public Health Clinical Center, Jinan, China.
Xueting ZhengDepartment of Gastroenterology, People's Hospital of Yangxin County, Binzhou, China.
Yang YangDepartment of Hepatology, Shandong Provincial Public Health Clinical Center, Jinan, China.ORCID 0000-0001-5338-0287
Shanghai Public Health Clinical Center · CNPeople's Hospital of Yangzhong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perfluorooctanoic acid (PFOA) can accumulate in the livers of humans and animals via the food chain, resulting into liver injury, which is closely related to intestinal flora dysbiosis. Gastrodin has been reported to have hepatoprotective effect. However, whether gastrodin can alleviate PFOA-induced liver injury via modulating gut microbiota remains unclear. Herein, a PFOA-induced liver injury model was established by gavage of PFOA (5 mg/kg body weight) in 2% Tween 80 solution once daily for 6 weeks in mice, and then gastrodin in saline (20 mg/kg body weight) was used once daily for 8 weeks to treat liver damage. The biochemical indexes associated with liver function, oxidative stress, and inflammatory factors were examined. Hematoxylin-eosin staining was used to determine the liver histopathological changes. Besides, 16S rRNA sequencing was used to analyze the difference of gut microbiota between the model and treatment groups. The results showed that gastrodin significantly improved the oxidative stress caused by PFOA. Intestinal flora analysis showed that gastrodin treatment significantly increased the relative abundance of probiotics, such as

Indexed as

Gastrointestinal MicrobiomeAnimalsBenzyl AlcoholsCaprylatesCecumCytokinesDisease Models, AnimalFatty Acids, VolatileFluorocarbonsGlucosidesHepatomegalyInflammation MediatorsLiverMaleMiceMice, Inbred C57BLBenzyl AlcoholsCaprylatesCytokinesFatty Acids, VolatileFluorocarbonsgastrodinGlucosidesInflammation Mediatorsperfluorooctanoic acidProtective Agentsgastrodingut microbiotaliver injuryPerfluorooctanoic acidshort-chain fatty acids

Identifiers

PMID34866532
PMCPMC8810172
OpenAlexW4200282167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.